The mission of this CD laboratory is to develop and apply technological innovations to establish Triple S (soft, safe, and smart) breast imaging. The CD Laboratory addresses the unmet need for patient-centered breast imaging that will lead to improved patient acceptance and participation in breast imaging to improve health outcomes. The CD Laboratory pursues the following specific goals:
1. Mammography-based imaging
We will develop a painless, low to no compression mammography technique without compromising image quality or diagnostic effectiveness by employing novel imaging technologies. We will also develop optimal and standardized contrast in CEM without compromising image quality and diagnostic performance by applying an artificial intelligence-based model.
2. Breast Magnetic Resonance Imaging (MRI)
We will innovate the MRI experience by introducing a wearable breast coil that allows comfortable measurement in the supine position. We will establish low-contrast to contrast-free MRI through technological improvements, the introduction of a high-relaxivity contrast agent, and the application of artificial intelligence.
3. Value of Patient-centered BI
We will confirm that the patient-centered Triple S (Soft, Safe, and Smart) approach developed in the CD laboratory is of value in preventing patient harm and discomfort while ensuring the safety of breast imaging, thereby increasing patient participation in breast imaging.
Programme
Welcome
- Michaela Fritz
Vice Rector for Research and Innovation of the Medical University Vienna - Martin Gerzabek
President of the Christian Doppler Research Association
Presentation of the Christian Doppler Laboratory for Patient-Centered Breast Imaging
- Pascal Baltzer
Head of the CD-Laboratory, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna - Joachim Bogner
Managing Director of Siemens Healthineers Austria - Martin Krix
Bracco Medical Leader for X-Ray and Ultrasound for Europe and Asia - Gerald Pressl
Managing Director of Alsix - Cristina Rossi
CEO of b-rayZ - Caroline Justich
Founder BeAccepted und patient-advisory group of the European Society of Radiology (ESR)
Moderation: Thomas Helbich, Vice Chairman, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna
Get-together
Registration
Partner
In Christian Doppler Laboratories, applicationoriented basic research is pursued at a high level, and expert scientists cooperate with innovative companies. The Christian Doppler Research Association is an international best practice example for promoting this collaboration.
Christian Doppler Laboratories are financed jointly by the public purse and the participating companies.The most important public sponsor is the Federal
Ministry for Labour and Economy (BMAW).
ALSIX GmbH iis a spin-off company founded by researchers from the Center for Medical Physics and Biomedical Engineering at the Medical University of Vienna, specialising in the development, production and distribution of hardware for Magnetic Resonance Imaging, in particular Radio Frequency.
Bracco Imaging develops, produces and markets contrast media, medicinal specialties used to improve the diagnostic accuracy of biomedical imaging and the management of patients with various diseases.
b-rayZ AG is a spin-off of the University Hospital of Zürich. The company's purpose is to develop and distribute in particular medical software and to provide related services in the areas of artificial intelligence and quality control.
Siemens Healthcare Diagnostics GmbH (SHD) is a leading medical technology company. Every day, an estimated five million patients worldwide benefit from its innovative technologies and services in a variety of areas including diagnostic and therapeutic imaging.